Heike-Katharina H. K.
- Country
- Germany
- Department
- Klinik und Poliklinik für Kinder- und Jugendmedizin
Research Overview
- Safety Follow-up Study to Assess the Safety of Romosozumab in Children and Adolescents with Osteogenesis Imperfecta
- Evaluation of Romosozumab Versus Bisphosphonates in Pediatric Osteogenesis Imperfecta: A Phase 3, Open-Label, Multicenter, Randomized Study
- Efficacy and Safety Evaluation of INCB000928 in Fibrodysplasia Ossificans Progressiva: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 15 of 50 partner sites.
Specializations
Rare Genetic Disorders
The investigator specializes in the study and treatment of Fibrodysplasia Ossificans Progressiva (FOP), a rare genetic condition affecting bone formation and development.
- Heterotopic Ossification Management
- Progressive Bone Formation Disorders
- Genetic Bone Diseases
Primary focus includes evaluating novel therapeutic approaches for preventing abnormal bone formation in FOP patients.
Therapeutic Development
Expertise in investigating innovative treatments for rare bone disorders, with particular emphasis on evaluating oral therapeutic agents for FOP management.
- Novel Drug Development
- Treatment Safety Assessment
- Clinical Efficacy Evaluation
Conducts research on both pediatric and adult populations to advance treatment options for progressive bone disorders.
Clinical Assessment
Specializes in advanced imaging and clinical evaluation methods, including whole body computed tomography for monitoring disease progression.
- Disease Monitoring Techniques
- Therapeutic Response Assessment
- Long-term Patient Outcomes
Implements comprehensive evaluation protocols to track treatment effectiveness in bone formation disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.